BamSEC and AlphaSense Join Forces
Learn More

Rapid Therapeutic Science Laboratories Inc

OTC: RTSL    
Share price (12/31/24): $0.00    
Market cap (12/31/24): $14.1 thousand

Material Contracts Filter

EX-10.2
from 8-K 21 pages Form of Common Stock Purchase Warrant Rapid Therapeutic Science Laboratories, Inc
12/34/56
EX-10.1
from 8-K 9 pages Form of Second Amendment, Waiver and Purchase Agreement
12/34/56
EX-10.34
from S-1/A 9 pages Common Stock Purchase Warrant
12/34/56
EX-10.3
from 8-K 20 pages Form of Common Stock Purchase Warrant Rapid Therapeutic Science Laboratories, Inc
12/34/56
EX-10.2
from 8-K 24 pages Form of Original Issue Discount Convertible Debenture Due on the Maturity Date
12/34/56
EX-10.1
from 8-K 8 pages Form of Amendment, Waiver and Purchase Agreement
12/34/56
EX-10.2
from 8-K 12 pages The Issue Price of This Note Is $400,000.00
12/34/56
EX-10.1
from 8-K 10 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 12 pages The Issue Price of This Note Is $173,738.00 the Original Issue Discount Is $19,988.00
12/34/56
EX-10.1
from 8-K 11 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 25 pages First Amended and Restated Rapid Therapeutic Science Laboratories, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.8
from 10-Q 34 pages Wells Asset Management North Texas Commercial Association of Realtors® Commercial Lease Agreement Between Triple D Rosegate, LLC (Landlord) and Rapid Therapeutic Scientific Laboratories, Inc
12/34/56
EX-10.3
from 8-K 4 pages Leak-Out Agreement
12/34/56
EX-10.2
from 8-K 24 pages Original Issue Discount Convertible Debenture Due May 1, 2022
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 3 pages Rapid Therapeutic Prepares to File Investigational New Drug Application for Its Cbd Metered Dose Inhaler With FDA
12/34/56
EX-10.3
from 8-K 9 pages Independent Contractor Agreement
12/34/56
EX-10.2
from 8-K 6 pages Trading Agreement
12/34/56
EX-10.1
from 8-K 11 pages Independent Contractor Agreement
12/34/56
EX-10.7
from 10-Q 13 pages The Securities to Be Issued Pursuant to This Agreement Have Not Been Registered Under the Securities Act of 1933, as Amended (“Securities Act”), or Any Other Applicable State Securities Laws and May Not Be Offered or Sold Unless Registered Thereunder or Unless an Exemption From Such Registration Is Available. Subscription Agreement $0.40 Per Share 2. Description of Securities; Risk Factors. A.DESCRIPTION of Securities. the Company Is Offering (The “Offering”) to the Investor Shares of the Company’s Common Stock (“Common Stock” or “Securities”) at a Purchase Price of $0.40 Per Share
12/34/56